The short answer
ortho-Toluidine is a chemical used to make dyes, rubber chemicals, and some pesticides. Occupational exposure is linked to bladder cancer. Workplace controls reduce exposure.
ortho-Toluidine is classified as a known human carcinogen (IARC Group 1).
People are mainly exposed by occupational contact in dye and rubber-chemical manufacturing.
It is most strongly linked to bladder cancer.
A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.
Choose how you want to understand this
The full explanation.
A liquid that goes into rubber, dye, and weed killer
o-Toluidine is a man-made liquid. Its other name is 2-methylbenzenamine. Safety sheets list it as CAS 95-53-4. Fresh, it is pale yellow. It darkens quickly in air and light. It belongs to a family of industrial chemicals called aromatic amines. Several members of that family are known to cause bladder cancer, including benzidine and 2-naphthylamine.
Three uses account for most of it:
- Rubber chemicals. These are the additives that make rubber tough and slow to age.
- Pesticide building blocks, mainly 4-chloro-o-toluidine and 6-ethyl-o-toluidine. The second one is used to make the weed killers metolachlor and acetochlor.
- Dyes and pigments. More than 90 dyes and pigments are made from it, either directly or through other intermediates.
Smaller uses include making the local anesthetic prilocaine, staining tissue for the lab, and mixing a reagent that measures glucose in blood samples. It is a high-production-volume chemical. EPA data put combined US production and imports at 50 million to 100 million pounds in 2015.
What the worker studies found
The federal listing rests on six studies in people. Three followed dye workers over time (Case and Pearson 1954, Ott and Langner 1983, Pira and colleagues 2010). Two followed rubber-chemical workers (Sorahan 2008, Carreón and colleagues 2014). One was a population-based case-control study (Richardson and colleagues 2007).
NTP called one study the most informative of the set. It is the NIOSH study of US rubber-chemical workers published by Carreón and colleagues in 2014. It had the best measurement of how much o-toluidine workers actually met, and of the other chemicals they met at the same time.
Four of the studies allowed enough latency. Latency is the waiting time between first exposure and a cancer showing up, and a study that is too short will miss real cases. All four found extra bladder cancer. Risk went up with the level of exposure, with how long the exposure lasted, and with time since it started. Two studies found no excess. NTP judged that one of those had very little power to detect an effect, and that exposure was probably misclassified in both.
From "reasonably anticipated" to "known"
The Report on Carcinogens is the federal list kept by the National Toxicology Program. It has two levels. The lower one is "reasonably anticipated to be a human carcinogen." The higher one is "known to be a human carcinogen."
o-Toluidine started at the lower level. It was first listed in the Third Annual Report in 1982, based on animal studies alone. Its salt form, o-toluidine hydrochloride, had been listed a year before that. The human studies published later changed the picture. The listing moved up to "known to be a human carcinogen" in the Thirteenth Report in 2014. It sits at that level in the current Fifteenth Report.
Three strands hold that listing up. Human studies show bladder cancer. Animal studies show cancer at several sites, including the bladder in rats, so the target organ matches. Mechanism studies show a plausible way it could do the same thing in people.
IARC, the cancer research arm of the World Health Organization, reviewed it in Volume 100F, published in 2012. That volume re-examined agents already classified as carcinogenic to humans, which is IARC's Group 1, and o-toluidine is one of the agents it covers.
Skin matters as much as air
Two routes get this chemical into the body: breathing the vapor, and touching the liquid. Both OSHA and the ACGIH attach a skin notation to o-toluidine. That notation is a formal flag. It means enough of the chemical can pass through intact skin to matter, so testing the air alone can badly understate the real dose.
Urine testing shows how wide the gap is between a job and ordinary life. In one study, urinary o-toluidine ran more than 26 times higher in exposed workers than in unexposed ones. Biological monitoring also finds low levels in people with no job exposure, in smokers and non-smokers alike. Hospital and laboratory staff meet small amounts through the glucose reagent and tissue-staining uses.
The numbers that apply on the job
- OSHA permissible exposure limit: 5 parts per million, averaged over a shift, with a dermal-absorption flag. This is the enforceable rule.
- ACGIH threshold limit value: 2 ppm, also with a skin notation. This is a guideline, not a law.
- NIOSH immediately dangerous to life and health level: 50 ppm. NIOSH also lists o-toluidine as a potential occupational carcinogen.
NTP adds a warning about the OSHA figure itself. That limit was adopted from a 1968 ACGIH value shortly after OSHA was created. NTP writes that it "may not reflect the most recent scientific evidence and may not adequately protect worker health."
Other federal rules attach as well. It is a hazardous air pollutant under the Clean Air Act. Its reportable quantity for a spill under CERCLA is 100 pounds. Its hazardous waste codes under RCRA are U222, U328, K112, K113 and K114. The Department of Transportation treats it as a hazardous material and a marine pollutant.
Sensible control follows from the skin route. That means closed transfer instead of open pouring, local exhaust at the point of release, chemical-resistant gloves and suits, immediate change out of splashed clothing, and washing before breaks.
If this was your trade
Exposure that happened decades ago can still be the relevant history today, because bladder cancer often takes many years to appear. Two practical things follow.
First, put the job history in writing where your care team can see it: the industry, the years, and the tasks. A history of dye, rubber-chemical or pesticide-intermediate work changes how a doctor reads a finding like blood in the urine. Our page on bladder cancer covers how that symptom is worked up.
Second, do not treat this as one isolated chemical. Aromatic amines were often used together in the same plants, and exposure records are usually incomplete. Our pages on benzidine and on carcinogens at work explain how these exposures are grouped and why old job records matter.
Sources
Words to know
Tap any term to see what it means.

Common questions
Does ortho-toluidine cause cancer?
Yes. ortho-Toluidine is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.
How are people exposed to ortho-toluidine?
Most exposure happens by occupational contact in dye and rubber-chemical manufacturing.
Which cancers are linked to ortho-toluidine?
It is most strongly linked to bladder cancer.
How can I reduce my exposure to ortho-toluidine?
The main steps are workplace controls and protective equipment.
Does a carcinogen label mean I will get cancer?
No. A classification is about hazard — whether ortho-toluidine can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-06Next planned review: 2028-07-05
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
